-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On ORIC Pharmaceuticals with Buy Rating, Announces Price Target of $26

Benzinga·09/23/2026 10:36:20
Listen to the news
BTIG analyst Jeet Mukherjee initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $26.